Skip to main content
Erschienen in: Supportive Care in Cancer 3/2019

06.08.2018 | Original Article

Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)

verfasst von: Fausto Roila, Guglielmo Fumi, Benedetta Ruggeri, Andrea Antonuzzo, Carla Ripamonti, Sonia Fatigoni, Luigi Cavanna, Stefania Gori, Alessandra Fabi, Nicola Marzano, Claudio Graiff, Vitaliana De Sanctis, Aurora Mirabile, Samantha Serpentini, Chiara Bocci, Maria Simona Pino, Giuseppina Cilenti, Claudio Verusio, Enzo Ballatori, on behalf of NICSO (Network Italiano per le Cure di Supporto in Oncologia)

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Fatigue is one of the most distressing symptoms of cancer patients. Its characteristics and impact on quality of life have not been fully explored and treatment of cancer-related fatigue in Italian oncological centers has not been codified.

Methods

A cross-sectional study was carried out on all patients attending for any reason the 24 participating centers in two non-consecutive days. Patients with fatigue filled out the Brief Fatigue Inventory (BFI) questionnaire and reported any pharmacological or non-pharmacological treatment for fatigue.

Results

From October 2014 to May 2015, 1394 cancer patients agreed to participate in the study. Fatigue was referred by 866 (62.1%) of patients; its duration was > 4 months in 441 patients (50.9%). In the investigators’ opinion, the most important (probable or almost sure) determinants of fatigue were reduced physical activity (271 patients), anxiety (149), pain (131), insomnia (125), anemia (123), and depression (123). Fatigue of moderate/severe intensity was reported by 43%/29.2% of patients, while usual fatigue in the last 24 h by 45%/33.1%, and the worst fatigue in the last 24 h by 33%/54.8%, respectively. Concerning the impact on quality of life, fatigue interfered moderately/severely with general activity in 30.8%/38.6% of patients, with mood in 26.1%/32.8%, with the ability to work in 27.9%/35.6%, with normal work in 26.7%/38.9%, with relationships with others in 21%/23.4% and with the ability to amuse themselves in 22.2%/33.1%. Only 117/866 patients (13.5%) received a pharmacological treatment represented by a corticosteroid in 101 patients (86.3%) while 188 patients (21.7%) received a non-pharmacological treatment such as physical exercise (120 patients, 63.8%) and various alimentary supplements (52 patients, 27.6%).

Conclusions

Cancer-related fatigue is frequently reported by oncological patients; its intensity and impact on quality of life is relevant.
Literatur
2.
Zurück zum Zitat Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB, American Society of Clinical Oncology (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology Clinical Practice Guideline Adaption. J Clin Oncol 32:1840–1850CrossRefPubMedPubMedCentral Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB, American Society of Clinical Oncology (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology Clinical Practice Guideline Adaption. J Clin Oncol 32:1840–1850CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Horneber M, Fischer I, Dimeo F et al (2012) Cancer-related fatigue: epidemiology, pathogenesis, diagnosis and treatment. Dtsch Arztebl Int 109:161–167PubMedPubMedCentral Horneber M, Fischer I, Dimeo F et al (2012) Cancer-related fatigue: epidemiology, pathogenesis, diagnosis and treatment. Dtsch Arztebl Int 109:161–167PubMedPubMedCentral
4.
Zurück zum Zitat Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P (2017) The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice? Breast 34:44–52CrossRefPubMed Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P (2017) The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice? Breast 34:44–52CrossRefPubMed
5.
Zurück zum Zitat Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22–34CrossRefPubMed Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22–34CrossRefPubMed
6.
Zurück zum Zitat Donovan KA, McGinty HL, Jacobsen PB (2013) A systematic review of research using the diagnostic criteria of cancer-related fatigue. Psychooncology 22:737–744CrossRefPubMed Donovan KA, McGinty HL, Jacobsen PB (2013) A systematic review of research using the diagnostic criteria of cancer-related fatigue. Psychooncology 22:737–744CrossRefPubMed
7.
Zurück zum Zitat Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR (2007) Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12(Suppl 1):11–21CrossRefPubMed Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR (2007) Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12(Suppl 1):11–21CrossRefPubMed
8.
Zurück zum Zitat Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20:17–25CrossRefPubMed Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20:17–25CrossRefPubMed
9.
Zurück zum Zitat Fisher MI, Davies C, Lacy H, Doherty D (2018) Oncology section EDGE task force on cancer: measures of cancer-related fatigue - a systematic review. Rehabil Oncol 36:93–105CrossRef Fisher MI, Davies C, Lacy H, Doherty D (2018) Oncology section EDGE task force on cancer: measures of cancer-related fatigue - a systematic review. Rehabil Oncol 36:93–105CrossRef
10.
Zurück zum Zitat Koornstra RHT, Peters M, Donofrio S, van den Borne B, de Jong FA (2014) Management of fatigue in patients with cancer- a practical overview. Cancer Treat Rev 40:791–799CrossRefPubMed Koornstra RHT, Peters M, Donofrio S, van den Borne B, de Jong FA (2014) Management of fatigue in patients with cancer- a practical overview. Cancer Treat Rev 40:791–799CrossRefPubMed
11.
Zurück zum Zitat Campos MPO, Hassan BJ, Riechelmann R, del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22:1273–1279CrossRefPubMed Campos MPO, Hassan BJ, Riechelmann R, del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22:1273–1279CrossRefPubMed
12.
Zurück zum Zitat Neefjes ECW, Van der Vorst MJ, Blauwhoff-Buskermolen S et al (2013) Aiming for a better understanding and management of cancer-related fatigue. Oncologist 18:1135–1143CrossRefPubMedPubMedCentral Neefjes ECW, Van der Vorst MJ, Blauwhoff-Buskermolen S et al (2013) Aiming for a better understanding and management of cancer-related fatigue. Oncologist 18:1135–1143CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bourmaud A, Anota A, Moncharmont C, Tinquaut F, Oriol M, Trillet-Lenoir V, Bajard A, Parnalland S, Rotonda C, Bonnetain F, Pérol D, Chauvin F (2017) Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomized controlled trial, the PEPs fatigue study. Br J Cancer 116:849–858CrossRefPubMedPubMedCentral Bourmaud A, Anota A, Moncharmont C, Tinquaut F, Oriol M, Trillet-Lenoir V, Bajard A, Parnalland S, Rotonda C, Bonnetain F, Pérol D, Chauvin F (2017) Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomized controlled trial, the PEPs fatigue study. Br J Cancer 116:849–858CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM (2017) Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 3:961–968CrossRefPubMedPubMedCentral Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM (2017) Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 3:961–968CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Howell D, Keller-Olaman, Oliver TK et al (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 20:e233–e246CrossRefPubMedPubMedCentral Howell D, Keller-Olaman, Oliver TK et al (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 20:e233–e246CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, Weisbrod BL (2014) Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment. Clin J Oncol Nurs 18(Suppl):38–58CrossRefPubMed Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, Weisbrod BL (2014) Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment. Clin J Oncol Nurs 18(Suppl):38–58CrossRefPubMed
17.
Zurück zum Zitat Cella D, Davis K, Breitbart W, Curt G, for the Fatigue Coalition (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391CrossRefPubMed Cella D, Davis K, Breitbart W, Curt G, for the Fatigue Coalition (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391CrossRefPubMed
18.
Zurück zum Zitat Respini D, Jacobsen PB, Thors C, Tralongo P, Balducci L (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273–279CrossRefPubMed Respini D, Jacobsen PB, Thors C, Tralongo P, Balducci L (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273–279CrossRefPubMed
19.
Zurück zum Zitat Teunissen SC, Wesker W, Kruitwagen C et al (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34:94–104CrossRef Teunissen SC, Wesker W, Kruitwagen C et al (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34:94–104CrossRef
20.
Zurück zum Zitat Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12PubMed Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12PubMed
21.
Zurück zum Zitat Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360CrossRef Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360CrossRef
22.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753CrossRefPubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753CrossRefPubMed
23.
Zurück zum Zitat Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13:589–598CrossRefPubMed Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13:589–598CrossRefPubMed
24.
Zurück zum Zitat Borneman T, Koczywas M, Sun V et al (2010) Reducing patient barriers to pain and fatigue management. J Pain Symptom Manag 39:486–501CrossRef Borneman T, Koczywas M, Sun V et al (2010) Reducing patient barriers to pain and fatigue management. J Pain Symptom Manag 39:486–501CrossRef
25.
Zurück zum Zitat Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice. CA Cancer J Clin 65:190–211CrossRefPubMed Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice. CA Cancer J Clin 65:190–211CrossRefPubMed
26.
Zurück zum Zitat Berger AM, Mooney K (2016) Dissemination and implementation of guidelines for cancer-related fatigue. J Natl Compr Cancer Netw 14:1336–1338CrossRef Berger AM, Mooney K (2016) Dissemination and implementation of guidelines for cancer-related fatigue. J Natl Compr Cancer Netw 14:1336–1338CrossRef
Metadaten
Titel
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
verfasst von
Fausto Roila
Guglielmo Fumi
Benedetta Ruggeri
Andrea Antonuzzo
Carla Ripamonti
Sonia Fatigoni
Luigi Cavanna
Stefania Gori
Alessandra Fabi
Nicola Marzano
Claudio Graiff
Vitaliana De Sanctis
Aurora Mirabile
Samantha Serpentini
Chiara Bocci
Maria Simona Pino
Giuseppina Cilenti
Claudio Verusio
Enzo Ballatori
on behalf of NICSO (Network Italiano per le Cure di Supporto in Oncologia)
Publikationsdatum
06.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4393-9

Weitere Artikel der Ausgabe 3/2019

Supportive Care in Cancer 3/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.